Dr. Li Xiaofeng
李小峰
Chief Physician; Professor; Director of Rheumatology Department; Distinguished Expert of Shanxi Province
Where they practice, who they consult.
- Second Hospital of Shanxi Medical University
- 30+ years in rheumatology
- English, Mandarin
What they personally lead.
Training and recognition
Built the rheumatology department at Second Hospital of Shanxi Medical University into a nationally recognized center for rheumatoid arthritis treatment; pioneered the adoption and optimization of biologic therapies (TNF inhibitors, IL-6 inhibitors, JAK inhibitors) for RA in northern China; led multi-center clinical trials on novel biologic agents; contributed to CRDC data collection and Chinese RA treatment guidelines; published in Annals of the Rheumatic Diseases, Chinese Medical Journal, and International Immunopharmacology
What to expect
Dr. Li offers deep expertise in biologic therapy selection and management for rheumatoid arthritis. Patients from northern China and those seeking specialized RA management outside the traditional Beijing/Shanghai axis will find his center well-equipped with modern infusion facilities and experienced nursing staff.
Check the public record
Look up publications, citations, and academic profile on independent platforms before reaching out.
Results are automated searches and may include other individuals with similar names.
Ask the AI or request a coordinator.
The AI can compare Li Xiaofeng's background to other specialists in China. A coordinator can confirm appointment availability and English-language support.
Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.